Literature DB >> 23085726

Factors associated with CKD in the elderly and nonelderly population.

Ming-Yen Lin1, Yi-Wen Chiu, Chien-Hung Lee, Hui-Yen Yu, Hung-Chun Chen, Ming-Tsang Wu, Shang-Jyh Hwang.   

Abstract

BACKGROUND AND OBJECTIVES: The risk factors for CKD in different age groups remain unknown. This community-based study aimed to identify the risk factors for CKD in elderly and nonelderly patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A multistage sampling survey for CKD was conducted in 2007 in Kaohsiung County, an area with the highest prevalence of dialysis in the world. CKD was defined as proteinuria in at least the microalbuminuric stage or an estimated GFR (eGFR) of <60 ml/min per 1.73 m(2). The factors for CKD in elderly and nonelderly patient groups were identified (with age 60 years as a cutoff value).
RESULTS: The analyses included 3352 participants, of whom 687 had CKD. The weighted prevalence of CKD was 19.4% (95% confidence interval [CI], 18.0%-20.7%). Elderly patients typically presented with low eGFR and nonelderly patients, with proteinuria. Age, annual income, use of oral analgesics, metabolic syndrome, hyperuricemia, and hemoglobin were risk factors for CKD in both age groups. In elderly patients, risk factors were medical history of diabetes mellitus, CKD, stroke, and not using analgesic injection (odds ratios [95% CIs], 3.58 [2.06-6.22], 3.66 [1.58-8.43], 3.89 [1.09-13.87], 2.27 [1.21-4.17], respectively). In nonelderly patients, associated risk factors for CKD were gout, hepatitis B virus infection, and use of the Chinese herbal medicine Long Dan Xie Gan Tang (odds ratios [95% CIs], 3.15 [1.96-5.07], 1.66 [1.09-2.53], and 8.86 [1.73-45.45], respectively).
CONCLUSIONS: The risk factors for CKD vary by age.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085726      PMCID: PMC3531659          DOI: 10.2215/CJN.05600612

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  30 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Chronic kidney disease.

Authors:  Andrew S Levey; Josef Coresh
Journal:  Lancet       Date:  2011-08-15       Impact factor: 79.321

3.  Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?

Authors:  J-F Huang; W-L Chuang; C-Y Dai; C-K Ho; S-J Hwang; S-C Chen; Z-Y Lin; L-Y Wang; W-Y Chang; M-L Yu
Journal:  J Intern Med       Date:  2006-09       Impact factor: 8.989

4.  Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.

Authors:  Gregorio T Obrador; Guillermo García-García; Antonio R Villa; Ximena Rubilar; Nadia Olvera; Evangelina Ferreira; Margarita Virgen; José Alfonso Gutiérrez-Padilla; Melissa Plascencia-Alonso; Martha Mendoza-García; Salvador Plascencia-Pérez
Journal:  Kidney Int Suppl       Date:  2010-03       Impact factor: 10.545

Review 5.  Screening for chronic kidney disease: which strategy?

Authors:  Stein I Hallan; Paul Stevens
Journal:  J Nephrol       Date:  2010 Mar-Apr       Impact factor: 3.902

6.  Prevalence of chronic kidney disease in the Japanese general population.

Authors:  Enyu Imai; Masaru Horio; Tsuyoshi Watanabe; Kunitoshi Iseki; Kunihiro Yamagata; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Toshiki Moriyama; Yasuhiro Ando; Shoichi Fujimoto; Tsuneo Konta; Hitoshi Yokoyama; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-11       Impact factor: 2.801

7.  Prevalence and factors associated with CKD: a population study from Beijing.

Authors:  LuXia Zhang; PuHong Zhang; Fang Wang; Li Zuo; Ying Zhou; Ying Shi; Gang Li; ShuFang Jiao; ZeJun Liu; WanNian Liang; HaiYan Wang
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

8.  All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

Authors:  Chi Pang Wen; Ting Yuan David Cheng; Min Kuang Tsai; Yen Chen Chang; Hui Ting Chan; Shan Pou Tsai; Po Huang Chiang; Chih Cheng Hsu; Pei Kun Sung; Yi Hua Hsu; Sung Feng Wen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

9.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

10.  End-stage renal disease in Taiwan: a case-control study.

Authors:  Su-Ying Tsai; Hung-Fu Tseng; Hsiu-Fen Tan; Yu-Shu Chien; Chia-Chu Chang
Journal:  J Epidemiol       Date:  2009-06-20       Impact factor: 3.211

View more
  16 in total

1.  Evaluation of glomerular filtration rate by different equations in Chinese elderly with chronic kidney disease.

Authors:  Guan Changjie; Zhu Xusheng; He Feng; Qin Shuguang; Li Jianwen; Fu Junzhou
Journal:  Int Urol Nephrol       Date:  2016-07-11       Impact factor: 2.370

Review 2.  Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Fabrizi; Simona Verdesca; Piergiorgio Messa; Paul Martin
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

3.  Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis.

Authors:  Gaurav Sharma; Abhishek Dubey; Nilesh Nolkha; Jasvinder A Singh
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-25       Impact factor: 5.346

4.  13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.

Authors:  Yi-Chun Chen; Yu-Chieh Su; Chung-Yi Li; Shih-Kai Hung
Journal:  BMC Nephrol       Date:  2015-07-22       Impact factor: 2.388

Review 5.  Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies.

Authors:  Matthew J Roughley; John Belcher; Christian D Mallen; Edward Roddy
Journal:  Arthritis Res Ther       Date:  2015-04-01       Impact factor: 5.156

6.  Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.

Authors:  Yi-Chun Chen; Wen-Yen Chiou; Shih-Kai Hung; Yu-Chieh Su; Shang-Jyh Hwang
Journal:  BMC Nephrol       Date:  2013-09-06       Impact factor: 2.388

7.  Addressing health disparities in chronic kidney disease.

Authors:  Ta-Chien Chan; I-Chun Fan; Michael Shi-Yung Liu; Ming-Daw Su; Po-Huang Chiang
Journal:  Int J Environ Res Public Health       Date:  2014-12-11       Impact factor: 3.390

8.  Risk factors of gender for renal progression in patients with early chronic kidney disease.

Authors:  Po-Ya Chang; Li-Nien Chien; Yuh-Feng Lin; Mai-Szu Wu; Wen-Ta Chiu; Hung-Yi Chiou
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

Authors:  Usman Mahmood; Helen G Healy; Adrian Kark; Anne Cameron; Zaimin Wang; Rajitha Abeysekera; Wendy E Hoy
Journal:  BMC Nephrol       Date:  2017-12-28       Impact factor: 2.388

10.  Determinants and burden of chronic kidney disease in a high-risk population in Korea: results from a cross-sectional study.

Authors:  Yong Un Kang; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Intern Med       Date:  2016-01-13       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.